Medical Technology Company Announces Definitive Agreement For Major Licensing

On July 15, 2024, Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a pioneering medical device firm dedicated to advancing innovative technologies for diagnosing and treating nervous system diseases, announced a development. The company has entered into a definitive agreement with RF Innovations, Inc., a privately held medical technology company, to license the intellectual property for its Apex 6 Radiofrequency Generator. This technology is FDA-cleared for ablation designed to lesion neural tissue, specifically targeting pain management in the peripheral nervous system. The transaction is anticipated to close before the end of July 2024. $Autonomix Medical(AMIX.US)$